Baclofen-mediated gastro-oesophageal acid reflux control in patients with established reflux disease

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 5, 2002, Pages 869-873

  Cange, L ^a   Johnsson, E ^a   Rydholm, H ^b   Lehmann, A ^b   Finizia, C ^a   Lundell, L ^a   Ruth, M ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; BACLOFEN; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; ESOPHAGUS PH; FATIGUE; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HEADACHE; HIATUS HERNIA; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

ADMINISTRATION, ORAL; ADULT; BACLOFEN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL;

EID: 0036240152     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01250.x     Document Type: Article

References (17)

1. Gastro-oesophageal reflux disease
2. Epidemiology of reflux disease and reflux esophagitis
3. Epidemiology and natural history of gastro-oesophageal reflux disease
4. Measurement of the impact of heartburn and dyspepsia on quality of life
5. Continued (5-year) follow up of a randomized clinical study comparing antireflux surgery and omeprazoie in gastroesophageal reflux disease
6. Site of action of GABA(B) receptor for vagal motor control of the lower esophageal sphincter in ferrets and rats
7. GABA(B) receptors on vagal afferent pathways: Peripheral and central inhibition
8. GABA(B) receptor-mediated effects on vagal pathways to the lower oesophageal sphincter and heart
9. GABA(B) receptors inhibit mechanosensitivity of primary afferent endings
10. Activation of the GABA(B) receptor inhibits transient lower esophageal sphincter relaxations in dogs
11. Inhibition of transient LES relaxations and reflux in ferrets by GABA receptor agonists
12. Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects
13. Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease
14. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: A meta-analysis of long-term omeprazole trials
15. Control of belching by the lower oesophageal sphincter
16. Systemic baclofen stimulates gastric motility and secretion via a central action in the rat
17. Modulation of the vagal drive to the intramural cholinergic and non-cholinergic neurones in the ferret stomach by baclofen